Orbitao SRL
Orbitao reported total assets of 384,076 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Oct 2025).
The score of Orbitao shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +867 % Total assets +84 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Orbitao's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 148,291 € | ||||
| Equity | 382,225 € | ||||
| Cash | 9,152 € | ||||
| EBITDA | 262,728 € | ||||
| Total assets | 384,076 € |
Filed annual accounts
- Year ended 31 Mar 2025filed on 29 Oct 2025
- Year ended 31 Mar 2024filed on 30 Oct 2024
- Year ended 31 Mar 2023filed on 27 Oct 2023
- Year ended 31 Mar 2022filed on 03 Nov 2022
- Year ended 31 Mar 2021filed on 03 Nov 2021
Orbitao's financial analysis
- Solvency99.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Orbitao
Orbitao's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0470.533.835
- VAT number
- BE0470533835
- Peppol
- Registered · 0208:0470533835 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Feb 2000
- Registered office
- 3630 Maasmechelen
- Latest accounts
- 2025 · filed on 29 Oct 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Orbitao (SRL) has been based in Maasmechelen since 2000, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 148,291 € and equity of 382,225 €; its revenue is not published. Its solvency stands at 99.5%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Orbitao
Companies in the same business, of comparable size and area, outside its group.
- Fortilab Distribution and Promotion Manufacture of pharmaceutical preparations Etterbeek · balance sheet 118,838 €
- HEW Pharma Manufacture of pharmaceutical preparations Kalmthout · balance sheet €1.01m
- Pannoc Chemie Manufacture of pharmaceutical preparations Olen · balance sheet €2.32m
- AIP Medical Manufacture of pharmaceutical preparations Olne · balance sheet €1.64m
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- Belipharm Wholesale of pharmaceutical and medical goods Leuven · balance sheet 449,785 €
- Sanifort Pharma Wholesale of pharmaceutical and medical goods Leuven · balance sheet 408,425 €
- Stylepharma Wholesale of pharmaceutical and medical goods Waterloo · balance sheet 503,082 €
Frequently asked questions about Orbitao
What is the revenue of Orbitao?
Orbitao files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Orbitao?
In Belgium, the VAT number is the company number prefixed with BE: BE0470533835 for Orbitao, if the company is VAT-registered. Its company number (CBE) is 0470.533.835.
Where is the registered office of Orbitao?
According to the CBE register, the registered office of Orbitao is in 3630 Maasmechelen.
What is the equity of Orbitao?
At the close of the 2025 financial year, the equity of Orbitao amounts to 382,225 €, a solvency of 99.5% of total assets.
Who manages Orbitao?
The register lists 1 active mandates at Orbitao. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Orbitao
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →